GCT1184-07: A Randomized, Open-label, Phase 3 Study of Rina-S ± Bevacizumab Versus Investigator's Choice of Platinum-Based Chemotherapy ± Bevacizumab as 2L Treatment in Participants With Recurrent Platinum-Sensitive Ovarian Cancer
- Title
- A Randomized, Open-label, Phase 3 Study of Rina-S ± Bevacizumab Versus Investigator's Choice of Platinum-Based Chemotherapy ± Bevacizumab as 2L Treatment in Participants With Recurrent Platinum-Sensitive Ovarian Cancer
- Principal Investigator
- Pfaendler, Krista
- Phase
- III (Cancer Control)
- Age Group
- Adult
- Applicable Disease Sites
- Gynecologic Cancers
- Participating Institutions
- Mary Babb Randolph Cancer Center
- Contacts
- Jill Stone, LPN
- Research Specialist
- Phone: +1 304-634-4417
- Email: jill.stone@hsc.wvu.edu